Evidence map›Paper›PMID 30201980›Full record

ArticleScientific reports2018

Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis.

Fanny Vardon Bounes, Vincent Mémier, Marina Marcaud, Aemilia Jacquemin, Hind Hamzeh-Cognasse, Cédric Garcia, Jennifer Series, Pierre Sié, Vincent Minville, Marie-Pierre Gratacap and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Early Platelet Dysfunction in Sepsis: An ICU Pilot Study.Pathogens (Basel, Switzerland) · 2026
    Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Western Diet Modifies Platelet Activation Profiles in Male Mice.International journal of molecular sciences · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Advances in Rodent Experimental Models of Sepsis.International journal of molecular sciences · 2023
    Review
  14. International journal of molecular sciences · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Fanny Vardon BounesINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France. bounes.f@chu-toulouse.fr.
Vincent MémierINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Marina MarcaudINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Aemilia JacqueminINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Hind Hamzeh-CognasseEA3064-GIMAP, Université de Lyon, Saint-Etienne, 42023, France.
Cédric GarciaHaematology laboratory, Centre hospitalier universitaire de Toulouse, Toulouse, 31400, France.
Jennifer SeriesHaematology laboratory, Centre hospitalier universitaire de Toulouse, Toulouse, 31400, France.
Pierre SiéINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Vincent MinvilleINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Marie-Pierre GratacapINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Bernard PayrastreINSERM, U1048 et Université Toulouse III, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, 31400, France.
Institut des Maladies Métaboliques et Cardiovasculaires · FRUniversité Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-12-JSV1-0012-01Fondation pour la Recherche Médicale (Foundation for Medical Research in France) DEQ20170336737
6 · The paper itself

Abstract

Sepsis is associated with thrombocytopenia and microvascular thrombosis. Studies have described platelets implication in this pathology but their kinetics of activation and behavior remain poorly known. We show in a mouse model of peritonitis, the appearance of platelet-rich thrombi in organ microvessels and organ damage. Complementary methods are necessary to characterize platelet activation during sepsis as circulating soluble markers and platelet-monocyte aggregates revealed early platelet activation, while surface activation markers were detected at later stage. A microfluidic based ex-vivo thrombosis assay demonstrated that platelets from septic mice have a prothrombotic behavior at shear rate encountered in microvessels. Interestingly, we found that even though phosphoinositide-3-kinase β-deficient platelet mice formed less thrombi in liver microcirculation, peritoneal sepsis activates a platelet alternative pathway to compensate the otherwise mandatory role of this lipid-kinase to form stable thrombi at high shear rate. Platelets are rapidly activated during sepsis. Thrombocytopenia can be attributed in part to platelet-rich thrombi formation in capillaries and platelet-leukocytes interactions. Platelets from septic mice have a prothrombotic phenotype at a shear rate encountered in arterioles. Further studies are necessary to unravel molecular mechanisms leading to this prothrombotic state of platelets in order to guide the development of future treatments of polymicrobial sepsis.

Indexed as

Platelet ActivationAnimalsArteriolesBlood PlateletsClass I Phosphatidylinositol 3-KinasesDisease Models, AnimalGene Knockdown TechniquesHumansMaleMiceMice, Inbred C57BLMice, TransgenicPeritonitisPlatelet Factor 4SepsisThrombocytopenia1-phosphatidylinositol 3-kinase p110 subunit, mouseClass I Phosphatidylinositol 3-KinasesPlatelet Factor 4

Identifiers

PMID30201980
PMCPMC6131186
OpenAlexW2889983174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.